{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:14:35Z","timestamp":1786994075578,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.medcli.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T13:23:42Z","timestamp":1724160222000},"page":"S4-S9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S1","title":["Antiphospholipid antibody testing"],"prefix":"10.1016","volume":"163","author":[{"given":"Savino","family":"Sciascia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Montaruli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Infantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.06.002_bib0295","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.medcli.2024.06.002_bib0300","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2024.06.002_bib0305","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood-2007-12-129627","article-title":"How we diagnose the antiphospholipid syndrome","volume":"113","author":"Giannakopoulos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2024.06.002_bib0310","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0315","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1177\/09612033231211820","article-title":"16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends","volume":"32","author":"Atsumi","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2024.06.002_bib0320","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0325","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/hematology.2023000493","article-title":"How to diagnose and manage antiphospholipid syndrome","volume":"2023","author":"Hubben","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.medcli.2024.06.002_bib0330","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ijlh.12234","article-title":"Antiphospholipid antibody testing and standardization","volume":"36","author":"Devreese","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0335","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1538-7836.2009.03316.x","article-title":"In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of \u03b22-glycoprotein I: proof of concept","volume":"7","author":"Ioannou","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0340","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1160\/TH11-05-0333","article-title":"Evolutionary conservation of the lipopolysaccharide binding site of \u03b22-glycoprotein I","volume":"106","author":"Agar","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0345","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-0716-3175-1_15","article-title":"An overview of laboratory testing for antiphospholipid antibodies","volume":"2663","author":"Favaloro","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0350","article-title":"Reporting and establishment of reference intervals for antiphospholipid antibody immunoassays: survey of participants in the college of American Pathologists Proficiency Testing Program","author":"Tebo","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.medcli.2024.06.002_bib0355","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/rheumatology\/keu360","article-title":"Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of \u03b22-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis","volume":"54","author":"Pericleous","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.medcli.2024.06.002_bib0360","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.3390\/jcm12206654","article-title":"Lupus anticoagulant detection under the magnifying glass","volume":"20","author":"Molinari","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2024.06.002_bib0365","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3175-1","article-title":"Variable performance of lupus anticoagulant testing: the Australasian\/Asia-Pacific Experience","author":"Favaloro","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0370","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/ijlh.13001","article-title":"Evaluation of an automated algorithm for interpretation of lupus anticoagulant testing","volume":"41","author":"Florin","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0375","doi-asserted-by":"crossref","first-page":"1075121","DOI":"10.3389\/fcvm.2023.1075121","article-title":"Application of the thrombin generation assay in patients with antiphospholipid syndrome: a systematic review of the literature","volume":"10","author":"Gehlen","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.medcli.2024.06.002_bib0380","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/jcm11082164","article-title":"Laboratory diagnosis of antiphospholipid syndrome: insights and hindrances","volume":"11","author":"Vandevelde","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2024.06.002_bib0385","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0041-1730357","article-title":"Laboratory approaches to test the function of antiphospholipid antibodies","volume":"48","author":"Szab\u00f3","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0390","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.thromres.2020.10.032","article-title":"Anti-\u03b22-glycoprotein I autoantibodies influence thrombin generation parameters via various mechanisms","volume":"197","author":"Szab\u00f3","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.medcli.2024.06.002_bib0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-0716-3175-1_19","article-title":"Antiphospholipid antibody testing for anti-cardiolipin and anti-\u03b22 glycoprotein I antibodies using chemiluminescenc based panels","volume":"2663","author":"Favaloro","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0400","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jth.13379","article-title":"IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis","volume":"14","author":"Kelchtermans","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0405","doi-asserted-by":"crossref","first-page":"e0156407","DOI":"10.1371\/journal.pone.0156407","article-title":"Measuring IgA anti-\u03b22-glycoprotein I and IgG\/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome","volume":"11","author":"Pericleous","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.medcli.2024.06.002_bib0410","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.autrev.2014.05.001","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends","volume":"13","author":"Bertolaccini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2024.06.002_bib0415","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0032-1311990","article-title":"Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I\u2014Anticardiolipin and anti-beta2-glycoprotein I antibodies","volume":"38","author":"Favaloro","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0420","doi-asserted-by":"crossref","first-page":"e71402","DOI":"10.1371\/journal.pone.0071402","article-title":"Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAs","volume":"8","author":"Pelkmans","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.medcli.2024.06.002_bib0425","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jth.12537","article-title":"Subcommittee on lupus anticoagulant\/phospholipid\/dependent antibodies. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH","volume":"12","author":"Devreese","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0430","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.thromres.2004.06.032","article-title":"An adapted ELISA method for differentiatin pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay","volume":"114","author":"Levy","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.medcli.2024.06.002_bib0435","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1751-553X.2010.01259.x","article-title":"Evaluation of three commercial ELISA kitfor anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome","volume":"33","author":"Decavele","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0440","first-page":"215","article-title":"Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986","volume":"68","author":"Harris","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0445","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-0033-1364207","article-title":"Standardization of antiphospholipid antibody testing\u2013historical perspectives and ongoing initiatives","volume":"40","author":"Willis","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0450","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ijlh.12234","article-title":"Antiphospholipid antibody testing and standardization","volume":"36","author":"Devreese","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0455","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cca.2011.09.048","article-title":"Standards and reference materials for the anticardiolipin and anti-beta2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies","volume":"413","author":"Pierangeli","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.medcli.2024.06.002_bib0460","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1515\/cclm-2020-0995","article-title":"Development of a certified reference material for anti-beta2-glycoprotein I IgG\u2014commutability studies","volume":"59","author":"Monogioudi","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.medcli.2024.06.002_bib0465","first-page":"101","article-title":"The Italian registry of antiphospholipid antibodies","volume":"82","author":"Finazzi","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2024.06.002_bib0470","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.STR.28.9.1660","article-title":"IgG anticardiolipin antibody titer>40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study","volume":"28","author":"Levine","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.medcli.2024.06.002_bib0475","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.thromres.2011.06.023","article-title":"Anticardiolipin and anti-beta2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: More than calculating the in-house 99th percentiles, even for new automated assays","volume":"128","author":"Devreese","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.medcli.2024.06.002_bib0480","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1177\/0961203318776105","article-title":"Revisiting the Phadia\/EliA cut-off values for anticardiolipin and antibeta2-glycoprotein I antibodies: a systematic evaluation according to the guidelines","volume":"27","author":"Bor","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2024.06.002_bib0485","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0002-9343(99)80014-X","article-title":"Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus","volume":"98","author":"Escalante","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.medcli.2024.06.002_bib0490","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0037-1613606","article-title":"Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies","volume":"90","author":"Neville","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0495","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.15585","article-title":"Semiquantitative interpretation of anticardiolipin and antibeta2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0500","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2024.06.002_bib0505","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1160\/TH04-12-0839","article-title":"Antibody profiles for the diagnosis of antiphospholipid syndrome","volume":"93","author":"Pengo","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0510","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0515","doi-asserted-by":"crossref","first-page":"7","DOI":"10.20452\/pamw.3253","article-title":"Four good reasons to appreciate triple positivity","volume":"126","author":"Pengo","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.medcli.2024.06.002_bib0520","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/jth.14560","volume":"17","author":"Cohen","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0525","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.autrev.2016.07.028","article-title":"APS\u2014diagnostics and challenges for the future","volume":"15","author":"Pengo","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2024.06.002_bib0530","doi-asserted-by":"crossref","first-page":"102641","DOI":"10.1016\/j.autrev.2020.102641","article-title":"Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome","volume":"19","author":"Sciascia","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2024.06.002_bib0535","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/biomedicines8120622","article-title":"Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine\/prothrombin antibodies","volume":"8","author":"Radin","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.medcli.2024.06.002_bib0540","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.jtha.2023.04.001","article-title":"Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"21","author":"Vandevelde","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0545","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/art.39187","article-title":"Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against \u03b22-glycoprotein i domain 1 and domain 4\/5: ratio of anti-domain 1 to anti-domain 4\/5 as a useful new biomarker for antiphospholipid syndrome","volume":"67","author":"Andreoli","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2024.06.002_bib0550","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/jth.12014","article-title":"Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities","volume":"10","author":"Sciascia","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0555","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-014-0415-x","article-title":"New tests to detect antiphospholipid antibodies: antiprothrombin (aPT) and antiphosphatidylserine\/prothrombin (aPS\/PT) antibodies","volume":"16","author":"Sciascia","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.medcli.2024.06.002_bib0560","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2","article-title":"Association of autoantibodies against the phosphatidylserine\u2013prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant","volume":"43","author":"Atsumi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2024.06.002_bib0565","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/ard.2010.145177","article-title":"Risk scale for the diagnosis of antiphospholipid syndrome","volume":"70","author":"Sciascia","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2024.06.002_bib0570","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/s-0040-1705115","article-title":"Antiphosphatidylserine\/prothrombin antibodies: an update on their association with clinical manifestations of antiphospholipid syndrome","volume":"120","author":"Radin","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.06.002_bib0575","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0961203314541317","article-title":"Thrombotic risk assessment in APS: the Global APS Score (GAPSS)","volume":"23","author":"Sciascia","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2024.06.002_bib0580","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/rheumatology\/kex466","article-title":"Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis","volume":"57","author":"Sciascia","year":"2018","journal-title":"Rheumatology (Oxford)"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324004330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324004330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T19:51:45Z","timestamp":1726602705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324004330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":58,"alternative-id":["S0025775324004330"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.06.002","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibody testing","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}